Abstract:Background Age‐associated aortic remodeling includes a marked increase in intimal medial thickness (IMT), associated with signs of inflammation. Although aortic wall milk fat globule–epidermal growth factor VIII (MFG‐E8) increases with age, and is associated with aortic inflammation, it is not known whether MFG‐E8 is required for the age‐associated increase in aortic IMT. Here, we tested whether MFG‐E8 is required for the age‐associated increase in aortic IMT. Methods and Results To determine the role of MFG‐E8 in the age‐associated increase of IMT, we compared aortic remodeling in adult (20‐week) and aged (96‐week) MFG‐E8 (−/−) knockout and age matched wild‐type (WT) littermate mice. The average aortic IMT increased with age in the WT from 50±10 to 70±20 μm ( P <0.0001) but did not significantly increase with age in MFG‐E8 knockout mice. Because angiotensin II signaling is implicated as a driver of age‐associated increase in IMT, we infused 30‐week‐old MFG‐E8 knockout and age‐matched littermate WT mice with angiotensin II or saline via osmotic mini‐pumps to determine whether MFG‐E8 is required for angiotensin II–induced aortic remodeling. (1) In WT mice, angiotensin II infusion substantially increased IMT, elastic lamina degradation, collagen deposition, and the proliferation of vascular smooth muscle cells; in contrast, these effects were significantly reduced in MFG‐E8 KO mice; (2) On a molecular level, angiotensin II treatment significantly increased the activation and expression of matrix metalloproteinase type 2, transforming growth factor beta 1, and its downstream signaling molecule phosphorylated mother against decapentaplegic homolog 2, and collagen type I production in WT mice; however, in the MFG‐E8 knockout mice, these molecular effects were significantly reduced; and (3) in WT mice, angiotensin II increased levels of aortic inflammatory markers phosphorylated nuclear factor‐kappa beta p65, monocyte chemoattractant protein 1, tumor necrosis factor alpha, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 molecular expression, while in contrast, these inflammatory markers did not change in knockout mice. Conclusions Thus, MFG‐E8 is required for both age‐associated proinflammatory aortic remodeling and also for the angiotensin II–dependent induction in younger mice of an aortic inflammatory phenotype observed in advanced age. Targeting MFG‐E8 would be a novel molecular approach to curb adverse arterial remodeling. Nonstandard Abbreviations and Acronyms AT1 angiotensin II receptor type 1 AT2 angiotensin II receptor type 2 ICAM1 intercellular adhesion molecule 1 IMT intimal medial thickness MCP1 monocyte chemoattractant protein 1 MFG‐E8 milk fat globule–epidermal growth factor VIII MMP2 matrix metalloproteinase type 2 NF‐κB p65 nuclear factor‐kappa beta p65 p‐NF‐κB p65 phosphorylated nuclear factor‐kappa beta p65 SMAD2 mother against decapentaplegic homolog 2 TGF‐β1 transforming growth factor beta 1 TNF‐α tumor necrosis factor alpha VCAM1 vascular cell adhesion molecule 1 VSMC vascular smooth muscle cell WT wild‐type Clinical Perspective What Is New? Milk fat globule–epidermal growth factor 8 increases with age and is required for age‐associated proinflammatory arterial remodeling that results in aortic intimal medial thickening. In younger mice, milk fat globule–epidermal growth factor 8 is also essential for angiotensin II–induced adverse arterial remodeling that mimics that which occurs in advanced age via the increase of proinflammation, intimal medial thickeni -Abstract Truncated-

Aging-induced isoDGR-modified fibronectin activates monocytic and endothelial cells to promote atherosclerosis

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

High levels of IsoDGR-modified fibronectin are associated with higher levels of macrophages and other rupture-prone plaque characteristics in patients undergoing carotid endarterectomy

MFG-E8 mediates arterial aging by promoting the proinflammatory phenotype of vascular smooth muscle cells

Age-linked lung pathology is reduced by immunotherapeutic targeting of isoDGR protein damage

Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signaling pathway

Age‐associated adipose tissue inflammation promotes monocyte chemotaxis and enhances atherosclerosis

Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells

Age-Associated Dysregulation of Integrin Function in Vascular Smooth Muscle

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis

Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated-M1 Macrophage Polarization-Dependent Vascular Smooth Muscle Cell Phenotypic Conversion

Fibronectin/α5 Integrin Contribute to Hypertension-Associated Arterial Ageing and Calcification through Affecting BMP2/MGP Imbalance and Enhancing Vascular Smooth Muscle Cell Phenotypic Transformation

Inflammatory Role of Milk Fat Globule-Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling.

Mechanisms of vascular inflammaging: TNF-alpha mediates endothelial CEACAM1 expression by NF-KB and beta-Catenin in a biphasic manner

G-MDSCs promote aging-related cardiac fibrosis by activating myofibroblasts and preventing senescence

Aging promotes mast cell activation and antigen presenting capacity in atherosclerosis

Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury

AGEs promote atherosclerosis by increasing LDL transcytosis across endothelial cells via RAGE/NF-κB/Caveolin-1 pathway

Peptide location fingerprinting identifies species- and tissue-conserved structural remodelling of proteins as a consequence of ageing and disease

Abstract 13125: The Role of FXR1 and Cellular Senescence in Vascular Pathology

Gsα Regulates Macrophage Foam Cell Formation During Atherosclerosis